Skip to Content

Medications for Pancreatic Cancer

Other names: Cancer, Pancreas; Cancer, Pancreatic; Pancreatic Carcinoma

What is Pancreatic Cancer:  Pancreatic carcinoma is a malignancy (cancer) of the pancreas.

Medications to treat Pancreatic Cancer

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Gemzar D N 3 reviews
7.0

Generic name: gemcitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Afinitor D N 1 review
9.0

Generic name: everolimus systemic

Drug class: mTOR inhibitors, selective immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
gemcitabine D N 3 reviews
7.0

Generic name: gemcitabine systemic

Brand name:  Gemzar

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Tarceva D N Add review Rate

Generic name: erlotinib systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
fluorouracil D N Add review Rate

Generic name: fluorouracil systemic

Brand name:  Adrucil

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Sutent D N 2 reviews
5.0

Generic name: sunitinib systemic

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Abraxane D N 1 review
1.0

Generic name: paclitaxel protein-bound systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

 
capecitabine Off Label D N Add review
9.0

Generic name: capecitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Adrucil D N Add review Rate

Generic name: fluorouracil systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
methotrexate Off Label X N X Add review Rate

Generic name: methotrexate systemic

Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Zanosar D N Add review Rate

Generic name: streptozocin systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
everolimus D N 1 review
9.0

Generic name: everolimus systemic

Brand name:  Afinitor

Drug class: mTOR inhibitors, selective immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
paclitaxel protein-bound D N 2 reviews
5.0

Generic name: paclitaxel protein-bound systemic

Brand name:  Abraxane

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts

 
Mutamycin N N Add review Rate

Generic name: mitomycin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
pancreatin Off Label C N Add review Rate

Generic name: pancreatin systemic

Drug class: digestive enzymes

For consumers: interactions, side effects

Off Label: Yes

 
erlotinib D N 1 review
5.0

Generic name: erlotinib systemic

Brand name:  Tarceva

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Onivyde N Add review Rate

Generic name: irinotecan liposomal systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

 
bevacizumab Off Label C N 1 review
9.0

Generic name: bevacizumab systemic

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Off Label: Yes

 
sunitinib D N 2 reviews
5.0

Generic name: sunitinib systemic

Brand name:  Sutent

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
mitomycin N N Add review Rate

Generic name: mitomycin systemic

Brand name:  Mutamycin

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
streptozocin D N Add review Rate

Generic name: streptozocin systemic

Brand name:  Zanosar

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
cetuximab Off Label C N Add review Rate

Generic name: cetuximab systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Off Label: Yes

 
irinotecan liposomal N Add review Rate

Generic name: irinotecan liposomal systemic

Brand name:  Onivyde

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts

 

Learn more about Pancreatic Cancer

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide